STAROSA Trial - Structured Testing and Treatment for Obstructive Sleep Apnea in Patients With Atrial Fibrillation
Sponsor: University Hospital, Antwerp
Trial Details
| Condition | Atrial Fibrillation, Obstructive Sleep Apnea |
| Intervention | (Cardio)Respiratory polygraphy (NOX T3s); Polysomnography; Devices to deliver Continuous Positive Airway Pressure (CPAP), Bilevel Positive Airway Pressure (BiPAP) or Adaptive support ventilation (ASV); Fitbit smartwatch |
| Phase | NA |
| Status | Recruiting |
| Participants | 209 |
| Est. Completion | 1 Feb 2028 |
| Last Updated | 8 May 2026 |
Primary Outcome
AF burden before and after CPAP treatment
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * Patients in whom AF (paroxysmal or persistent) is diagnosed with a 12-lead ECG * Patients who experience symptoms of their AF (mEHRA ≥ 2a) * Older than 18 years * Owning a smartphone compatible with Fitbit and FibriCheck applications (i.e. recent versions of Apple iOS or Android drivers) * Ability to sign the informed consent Exclusion Criteria: * Patients diagnosed with permanent AF or only atrial flutter * Prior/recent polysomnography evaluation * Prior/active CPAP/BiPAP/ASV treatment * Cognitive impairment * Inability to speak or fully understand Dutch * Pacemaker-dependent heart rhythm
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service